Avivagen Inc VIVXF

Consumer Defensive Farm Products

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.

GREY:VIVXF - Post by User

Avivagen Inc

Bullboard Posts

Comment by calderneton Oct 14, 2016 2:52pm

154 Views

Post# 25344756

RE:100 million market cap importance

And just for sake of doing the math....

$100,000,000 divided by ~272,600,000 outstanding shares = ~$0.36 to $037 sp.
which should be an attainable goal we hope.

Bullboard Posts

Anaergia expands relationship with PepsiCo